Articles in Press

Past Issues

About tcr

Manuscript Submission

AME Editing Service

Reprint & Permission

Advertising

Contact us

Announcement more

Welcome to the 2026 Clinical Research Innovation Forum & Editors-in-Chief Meet-and-Greet

We are pleased to invite you to join the 2026 Clinical Research Innovation Forum & Editors-in-Chief Meet-and-Greet co-organized by AME Publishing Company and Wolters Kluwer.The eve... More >>

Join us at the 41st Annual EAU Congress (EAU26)

The 41st Annual EAU Congress (EAU26), Europe’s biggest urological event, is going to be held in London, UK from March 13 to 16, 2026 More >>

TCR 2025 Annual Report

Greetings from the Editorial Office of TCR! More >>

Editorial

Axillary surgery after neoadjuvant therapy: rethinking completion axillary dissection for residual micrometastatic disease
Mariam Rizk, Kinan Mokbel, Kefah Mokbel
Translational Cancer Research  
2026;
15
(4)
:225
.
 (30 April 2026) 
PDF Full Text (163) Peer Review File COI Form Open Access Get Permission

Original Article

Establishing the role of the neurotransmitter receptor-related gene GABRD in the diagnosis, prognosis and immune infiltrates of colorectal cancer by bioinformatics analysis and experimental validation
Leiyan Wei, Wu Zhu, Zhiqin Guo, Hong Zhang, Linna Yuan, Lin Zhang, Bohao Sun, Shaoqing Hu, Jing Zhang, Wanxin Wu, Xiangyi Chen
Translational Cancer Research  
2026;
15
(4)
:226
.
 (30 April 2026) 
PDF Full Text (120) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Serum amyloid A1 promote progression of breast cancer and is associated with epithelial-mesenchymal transition
Jiali Lin, Xiaozhi Huang, Liuxian Pan, Mingli Li, Langhuan Lei, Xing Yang, Wei Shi, Yanping Ding, Ziqiong Jiang, Wei Li, Qiuyu Liang
Translational Cancer Research  
2026;
15
(4)
:227
.
 (30 April 2026) 
PDF Full Text (91) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Association of primary lesion surgery and surgical modality with overall survival in patients with stage IV cutaneous melanoma: a population-based study
Dun-Chang Mo, Long Chen, Yong-Jun Du, Peng-Hui Luo, Shang-Xiao Huang, Han-Lei Wang, Xiu-Juan Liang, Peng Lin, Jian-Feng Huang
Translational Cancer Research  
2026;
15
(4)
:228
.
 (30 April 2026) 
PDF Full Text (60) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Impact of the immuno-oncology era on cerebrovascular disease and cancer-specific mortality in older adults with advanced non-small cell lung cancer: a competing-risks cohort study
Meijun Zhou, Yujuan Huang, Cheng Yu, Guang Yao, You Li, Gai Xiao, Yana Chen, Huiyun Yu
Translational Cancer Research  
2026;
15
(4)
:229
.
 (30 April 2026) 
PDF Full Text (59) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Development and validation of a multi-task deep learning model integrating PET-CT radiomics, clinical variables, and EBV DNA for prognostic prediction in locally advanced nasopharyngeal carcinoma
Jian Zhang, Yi Luo, Shuting Lai, Yunlong Lou, Haidong Yu, Lang Peng
Translational Cancer Research  
2026;
15
(4)
:230
.
 (30 April 2026) 
PDF Full Text (60) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Investigation of immunohistochemical marker expression in breast cancer of varying severity and construction of a predictive model
Zhihao Zhai, Jiuqing Chi, Caixia Li, Qingjun Li, Xin Du, Yanuo Li, Xiaowu Wang
Translational Cancer Research  
2026;
15
(4)
:231
.
 (30 April 2026) 
PDF Full Text (78) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Identifying research gaps in PIK3CA-mutant breast cancer: a bibliometric analysis of evolving trends and clinical applications
Min Yan, Xinyu Li, Fanfan Li
Translational Cancer Research  
2026;
15
(4)
:232
.
 (30 April 2026) 
PDF Full Text (46) Reporting Checklist Peer Review File COI Form Open Access Get Permission
PD-1-targeted therapeutic strategies for advanced or recurrent gastric and gastroesophageal junction cancer: a systematic review and network meta-analysis
Yuxin Liu, Manling Zhou, Junjie Xi, Gege Sun, Zeyu Wang
Translational Cancer Research  
2026;
15
(4)
:233
.
 (30 April 2026) 
PDF Full Text (50) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Analyses of single-cell and bulk RNA-sequencing datasets identify biomarker-based molecular subtypes and a prognostic signature in lung adenocarcinoma
Minshan Fang, Xiuxia Zheng
Translational Cancer Research  
2026;
15
(4)
:234
.
 (30 April 2026) 
PDF Full Text (55) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
PTTG1-DLX2 axis drives malignant progression of lung adenocarcinoma by activating the WNT/β-catenin signaling pathway
Huili Chen, Xinyu Zhang, Xiaofu Lian, Ziqiang Wang, Feiyue Zhang, Jing Zhang, Shengping Min, Shasha Yang, Xiaojing Wang, Chaoqun Lian
Translational Cancer Research  
2026;
15
(4)
:235
.
 (30 April 2026) 
PDF Full Text (55) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Dairy product consumption and thyroid cancer risk: a systematic review and meta-analysis of observational studies
Xin Song, Jiarui Li, Mingxiu Sun, Ming Tang, Kaize Zheng, Siyu Li, Likun Du
Translational Cancer Research  
2026;
15
(4)
:236
.
 (30 April 2026) 
PDF Full Text (44) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Integrating multiple omics and machine learning to reveal the prognostic value of endoplasmic reticulum stress gene FKBP10 in gastric cancer
Xuanyu Chen, Chenchen Liu, Yuqin Wang, Aoyang Yu, Zichen Pei, Zhiyuan Yao, Gengchen Li, Lin Yan, Xitai Zhang, Zhengxiang Han
Translational Cancer Research  
2026;
15
(4)
:237
.
 (30 April 2026) 
PDF Full Text (76) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
The role of the CDCA gene family in tumor stemness maintenance and drug sensitivity
Lin Xiang, Tian Peng, Guo-Bin Song, Hou-Qun Ying, Xue-Xin Cheng
Translational Cancer Research  
2026;
15
(4)
:238
.
 (30 April 2026) 
PDF Full Text (54) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Identification of a novel ion channel-related gene signature to predict prognosis and immune response of gastric cancer
Xixian Zhao, Liuye Huang
Translational Cancer Research  
2026;
15
(4)
:239
.
 (30 April 2026) 
PDF Full Text (44) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Single-cell and bulk transcriptomic analyses identify B-cell senescence-associated biomarkers in papillary thyroid carcinoma
Tenghong Liu, Zhijun Chen, Hongyi Wu, Wenxin Zhao
Translational Cancer Research  
2026;
15
(4)
:240
.
 (30 April 2026) 
PDF Full Text (45) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Establishment and evaluation of a prognostic model for sodium overload necrosis in acute myeloid leukemia
Kunying Xie, Jin Wei
Translational Cancer Research  
2026;
15
(4)
:241
.
 (30 April 2026) 
PDF Full Text (30) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Molecular mechanism of miR-27a-3p targeting FBXW7 regulating the malignant behavior of osteosarcoma cells
Huaibin Zhang, Rongxuan Liu, Xiaorong Liu, Wenqiang Liang, Wenji Wang, Yongping Wang
Translational Cancer Research  
2026;
15
(4)
:242
.
 (30 April 2026) 
PDF Full Text (35) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Black ginseng extract suppresses lung cancer growth in a xenograft mouse model
Hye Jin Park, Ha Rin Namkung, Su Bin Jung, Kwang-Tae Choi, Seung Tae Lee
Translational Cancer Research  
2026;
15
(4)
:243
.
 (30 April 2026) 
PDF Full Text (64) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Multiomic characterization of response and resistance to neoadjuvant chemoradiotherapy in esophageal squamous cell carcinoma
Yue Li, Jun Liu, Wen Yu, Xin-Yun Song, Xu-Wei Cai, Guang-Zhong Wang, Xiao-Long Fu
Translational Cancer Research  
2026;
15
(4)
:244
.
 (30 April 2026) 
PDF Full Text (45) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Overexpression of FOXO1 may suppress proliferation and migration and correlate with tumor immune cells in nasopharyngeal carcinoma
Peng Yu, Wenyang Wei, Guoqing Wu, Xuexiang Liu, Shini Qin, Han Ma, Leru Feng, Yonglin Cai, Limin Liu
Translational Cancer Research  
2026;
15
(4)
:245
.
 (30 April 2026) 
PDF Full Text (57) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
The obesity paradox effect of triglyceride-glucose-body mass index (TyG-BMI) on all-cause mortality in patients with malignant tumors: a machine learning-driven cohort study
Mingxing Wang, Yahao Li, Jian Chen, Wanhui Dong, Yuru Wang, Siyi Bo, Pantong Wu, Zhiying Wang, Zhixian Zhong, Yi Zhong
Translational Cancer Research  
2026;
15
(4)
:246
.
 (30 April 2026) 
PDF Full Text (44) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Plasma fatty acid associated with risk of gastrointestinal cancer: a prospective cohort study from UK Biobank
Tianyu Song, Sien Hu, Yongji Sun, Jian Wu, Yulian Wu, Xiawei Li
Translational Cancer Research  
2026;
15
(4)
:247
.
 (30 April 2026) 
PDF Full Text (37) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Knockdown of TRIM35 suppresses cell proliferation and metastasis by modulating the PPAR signalling pathway in papillary thyroid cancer cells
Liubing Zhang, Aiping Peng, Yue Qin
Translational Cancer Research  
2026;
15
(4)
:248
.
 (30 April 2026) 
PDF Full Text (41) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Lipid metabolism-related gene expression predicts prognostic outcomes in lung adenocarcinoma
Xianyong Li, Qianqian Tang, Xuankai Wang, Na Liu, Jianjun Xu
Translational Cancer Research  
2026;
15
(4)
:249
.
 (30 April 2026) 
PDF Full Text (35) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Translational progress and bottlenecks in neurotransmitter-cancer research [2000–2025]: an integrated bibliometric and interventional trial analysis
Ming Zhang, Weihao Sun, Yizhao Ma, Jialin C. Zheng, Qihui Wu, Ge Gao
Translational Cancer Research  
2026;
15
(4)
:250
.
 (30 April 2026) 
PDF Full Text (33) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Construction of an actin cytoskeleton-related gene signature for predicting prognosis and therapeutic response in glioblastoma: based on machine learning
Mengda Li, Juntao Li, Zhixiao Li, Guanzheng Liu, Yuanhang Zhou, Mayuan Meng, Zikuan Chai, Ye Yuan, Chao Wang, Xudong Fu, Chunxiao Ma
Translational Cancer Research  
2026;
15
(4)
:251
.
 (30 April 2026) 
PDF Full Text (46) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Overexpression of ACTL6A is associated with poor prognosis in gastric cancer, and nuclear level is an independent predictor
Qiqi Wang, Haihong He, Yiwen Zhou, Peng Li, Tingting Huang
Translational Cancer Research  
2026;
15
(4)
:252
.
 (30 April 2026) 
PDF Full Text (62) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
A novel risk model of cholesterol metabolism-related mRNAs for predicting overall survival and immune signature in glioma based on machine learning and multi-omics data
Danlei Yu, Kecheng Shen, Jun Wang, Fan Jiang, Pengfei Xia, Zhengquan Yu
Translational Cancer Research  
2026;
15
(4)
:253
.
 (30 April 2026) 
PDF Full Text (40) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Non-coding RNAs (ncRNAs)-mediated high expression of Ras-related C3 botulinum toxin substrate 1 (RAC1) correlates with poor prognosis and tumor immune infiltration of liver hepatocellular carcinoma
Tao Zhang, Tao Jiang, Yuting Jiang, Ren Lang, Qiang He
Translational Cancer Research  
2026;
15
(4)
:254
.
 (30 April 2026) 
PDF Full Text (39) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Results of the feasibility study of clinical trials of the new cancer treatment technology Karanahan for patients with advanced breast cancer
Anastasia S. Proskurina, Veronika A. Markina, Vera S. Ruzanova, Genrikh S. Ritter, Evgeniya V. Dolgova, Svetlana S. Kirikovich, Evgeniy V. Levites, Yaroslav R. Efremov, Eugene I. Vereschagin, Olga Y. Leplina, Alexandr A. Ostanin, Elena R. Chernykh, Nikolay A. Kolchanov, Sergey V. Sidorov, Sergey S. Bogachev
Translational Cancer Research  
2026;
15
(4)
:255
.
 (30 April 2026) 
PDF Full Text (34) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Long non-coding RNA (lncRNA) CDKN2A-DT promotes proliferation, migration, and invasion of oral squamous cell carcinoma via the PI3K/AKT/mTOR axis
Ke Liao, Wei Lv, Binghua Feng, Xiaoping Su, Xuanping Huang
Translational Cancer Research  
2026;
15
(4)
:256
.
 (30 April 2026) 
PDF Full Text (49) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
CLIP2 is a potential biomarker for platinum resistance and prognosis in ovarian cancer: a bioinformatics analysis
Minghui Qiu, Mengxing Zhao, Jiani Zhao, Haoyun Zhao, Weiqi Jiang, Lu Yang, Lindong Yang
Translational Cancer Research  
2026;
15
(4)
:257
.
 (30 April 2026) 
PDF Full Text (41) Reporting Checklist Peer Review File COI Form Open Access Get Permission
OSBPL3 promotes colorectal cancer progression through modulation of TGF-β signaling and immune cell infiltration
Weijun Liang, Chengxing Wang, Jianchang Wei, Chaorong Zhou, Canxiu He, Yaoming He, Jinglin Zhao, Shangren Li, Jie Cao
Translational Cancer Research  
2026;
15
(4)
:258
.
 (30 April 2026) 
PDF Full Text (39) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
A2M promotes the progression of STAD by upregulating vimentin expression and epithelial-mesenchymal transition: boinformatics analysis and experimental verification
Wenyan Jiang, Guowen Ma, Huakai Zeng, Xinyue Xu, Junyi Liu, Xiaoke Wang, Yuyao Li, Xindi Huang, Wenjie Xu, Chunyan Fang, Wenqi Sun, Xuejian Wang
Translational Cancer Research  
2026;
15
(4)
:259
.
 (30 April 2026) 
PDF Full Text (38) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Nomogram prediction for breast cancer-specific survival in patients with ER−/PR−/HER2+ breast cancer: an analysis based on the SEER population
Li You, Yiman Ge, Jiangyan Yong, Yuye Li, Lingling Zhang, Qiongying Hu
Translational Cancer Research  
2026;
15
(4)
:260
.
 (30 April 2026) 
PDF Full Text (40) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Integrated transcriptomic analysis and machine learning identify immunogenic cell death genes as prognostic markers and therapeutic targets in non-small cell lung cancer
Xiaodong Chen, Tongtong Zhang, Zhe Yang, Fang Zhang
Translational Cancer Research  
2026;
15
(4)
:261
.
 (30 April 2026) 
PDF Full Text (51) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Optimization of temporal phase in multi-phase contrast-enhanced MRI for gross tumor volume determination in pancreatic cancer radiotherapy
Kangning Meng, Yujie Guo, Yong Yin, Ya Su, Lizhen Wang, Ruozheng Wang, Guanzhong Gong
Translational Cancer Research  
2026;
15
(4)
:262
.
 (30 April 2026) 
PDF Full Text (29) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Development and multicenter validation of an immunoinflammatory marker-MRI model for pathological complete response after neoadjuvant chemotherapy in invasive breast cancer
Fan Meng, Yanfang Deng, Junhui Yuan, Shaobo Fang, Hongkai Zhang, Tiandong Chen, Renzhi Zhang, Yunjing Xue, Xuejun Chen, Jinrong Qu
Translational Cancer Research  
2026;
15
(4)
:263
.
 (30 April 2026) 
PDF Full Text (32) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Integrating single-cell and spatial transcriptomics to decipher the neuro-immune microenvironment of breast cancer brain metastasis: a key regulatory axis, prognostic model, and drug discovery
Jing Li, Weiyi Wu, Jingkang Lu, Huan Yang, Yongling Leng, Bingxi Lei
Translational Cancer Research  
2026;
15
(4)
:264
.
 (30 April 2026) 
PDF Full Text (51) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Construction of a prognostic risk model based on colorectal cancer-specific ferroptosis genes and preliminary validation of FGFR4
Aduo Gao, Lina Tang, Xiangyan Meng, Minghui Zhang, Shengjie Yin
Translational Cancer Research  
2026;
15
(4)
:265
.
 (30 April 2026) 
PDF Full Text (37) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Ferroptosis-related lncRNA signature predicts prognosis and treatment response in colon cancer
Ting Wang, Chengyi Wang, Yubing Lu, Yanfeng Zhong, Yangyang Xue, Xin Liu, Erbao Chen, Guoqing Lv
Translational Cancer Research  
2026;
15
(4)
:266
.
 (30 April 2026) 
PDF Full Text (28) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
UBA6 serves as a prognostic biomarker and promotes tumor progression in pancreatic ductal adenocarcinoma
Zesha Xu, Yinghua Zhang, Ying Wang
Translational Cancer Research  
2026;
15
(4)
:267
.
 (30 April 2026) 
PDF Full Text (45) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Metaxins regulate cancer stem cell-like properties in H1299 cells
Heabin Kim, Seung-Hyun Jung, Seonmi Jo, Jeong Moo Han, Jei Ha Lee
Translational Cancer Research  
2026;
15
(4)
:268
.
 (30 April 2026) 
PDF Full Text (33) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Multi-omics analysis identifies RARRES1 as a potential biomarker linked to immunosuppressive microenvironment and its radiomics prediction in ovarian cancer
Tao Yang, Mao Hua, Deguo Xu
Translational Cancer Research  
2026;
15
(4)
:269
.
 (30 April 2026) 
PDF Full Text (43) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Tertiary lymphoid structure-related genes drive tumor microenvironment heterogeneity and prognostic disparities in left- vs. right-sided colon cancer
Hongyi Zhou, Xiaohong Qian, Qiujun Dai, Qiqi Zhu, Peiyuan Li, Wei Cui, Yibin Zhao
Translational Cancer Research  
2026;
15
(4)
:270
.
 (30 April 2026) 
PDF Full Text (32) Reporting Checklist Peer Review File COI Form Open Access Get Permission
A novel programmed-cell-death-related prognostic risk model for cervical cancer based on mitochondrial genes
Liping Cao, Chi Zhang
Translational Cancer Research  
2026;
15
(4)
:271
.
 (30 April 2026) 
PDF Full Text (31) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Asporin promotes gastric cancer progression by regulating NRF2 ubiquitination and competitively binding to KEAP1
Lei Yin, Mingming Du, Jieping Ying, Xiang Zhong, Feiran Wang, Nannan Zhang, Zhong Chen
Translational Cancer Research  
2026;
15
(4)
:272
.
 (30 April 2026) 
PDF Full Text (29) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Multi-omics clustering combined with multiple machine learning to identify epigenetic features in low-grade glioma patients
Lixuan Qiu, Xiaofu Lian, Xiaoyu Qiang, Chaoqun Lian, Jing Zhang
Translational Cancer Research  
2026;
15
(4)
:273
.
 (30 April 2026) 
PDF Full Text (35) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Chromatin remodeling-driven stratification and a five-gene RiskScore define proliferative aggressiveness and therapeutic vulnerabilities in neuroblastoma
Aiguo Zhu, Xin Li, Zhengchao Jin, Yi Pan, Jian Wang
Translational Cancer Research  
2026;
15
(4)
:274
.
 (30 April 2026) 
PDF Full Text (34) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Exploring the significance of IgM expression in the lymphatic system during breast cancer progression
Dingyuan Cui, Jie Li, Guangfei Yang, Wen Wang, Chengrong Mi
Translational Cancer Research  
2026;
15
(4)
:275
.
 (30 April 2026) 
PDF Full Text (45) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Construction and external validation of a nomogram for predicting 10-year recurrence risk after radical resection in Chinese patients with stage III colorectal cancer
Qingliang Wu, Liangxiao Wu, Yongjin He, Guoqing Yu, Dandan Chen
Translational Cancer Research  
2026;
15
(4)
:276
.
 (30 April 2026) 
PDF Full Text (30) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Integrated analysis of the prognostic and immunotherapeutic significance of ZEB1-AS1 in hepatocellular carcinoma
Xiangdong Niu, Yifeng Chen, Jing Yu, Xue Chen, Xuyun Wang, Guogan Ding, Liangyin Fu, Xiangyong Hao
Translational Cancer Research  
2026;
15
(4)
:277
.
 (30 April 2026) 
PDF Full Text (39) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Radiation-activated astrocytes promote tumor progression through CXCL12 secretion and induce resistance to anti-PD-1 immunotherapy
Xinlong Li, Haotian Wei, Yufeng Zhu, Peng Feng, Juncheng Wang, Guoqiang Yuan, Yawen Pan
Translational Cancer Research  
2026;
15
(4)
:278
.
 (30 April 2026) 
PDF Full Text (34) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Deciphering the molecular crosstalk between pancreatic ductal adenocarcinoma and type 2 diabetes through multi-dataset integration
Fan-Jie Jin, Jian-Fang Li, Hong-Yong Fu, Liang-Jun Xie, Lu-Ping Qin, Mu-Hua Cheng
Translational Cancer Research  
2026;
15
(4)
:279
.
 (30 April 2026) 
PDF Full Text (30) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Lysine crotonylation-related long non-coding RNAs: a novel prognostic framework for gastric carcinoma
Hao Hu, Hegui Zhao, Daiyi Yao, Qulai Tang, Chenghong Mou, Yang Deng
Translational Cancer Research  
2026;
15
(4)
:280
.
 (30 April 2026) 
PDF Full Text (31) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Development and validation of a non-invasive nomogram for predicting bone metastasis in newly diagnosed breast cancer
Li Wang, Xin Zhang, Simin Lu, Shourong Liu
Translational Cancer Research  
2026;
15
(4)
:281
.
 (30 April 2026) 
PDF Full Text (25) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Magnetic resonance imaging-based radiomics analysis: predicting vascular invasion in breast invasive ductal carcinoma using different machine learning models
Hongen Li, Li Zhang, Yihui Zeng, Yan Zhang, Zhiqiu Ye
Translational Cancer Research  
2026;
15
(4)
:282
.
 (30 April 2026) 
PDF Full Text (32) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Bioinformatics analysis of PBLD as a potential biomarker in pan-cancer and colon adenocarcinoma
Jiayue Chen, Xiaoqiong Chen, Yuanhao Wei, Jinyuan Ou, Lanxi Yue, Xuanle Li, Bing Huang, Fachao Zhi, Xinmei Zhao
Translational Cancer Research  
2026;
15
(4)
:283
.
 (30 April 2026) 
PDF Full Text (39) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Establishment and validation of a novel anoikis-related prognostic signature of lung squamous cell carcinoma
Zhengpan Wei, Kaishang Zhang, Kaiyuan Li, Shaowu Sun, Xu Liu, Wenbo Fan, Zelong Wang, Tianliang Zhao, Tongfa Yan, Bin Yan, Zhiqian Zhao, Qihang Zhao, Guoqing Zhang, Xue Pan, Xiangnan Li
Translational Cancer Research  
2026;
15
(4)
:284
.
 (30 April 2026) 
PDF Full Text (32) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Identification of EFNA family as new potential prognostic biomarkers correlated with immune cell infiltration in hepatocellular carcinoma
Junjun Wang, Xiaorui Li, Biyun Zheng, Zhixin Chen, Fenglin Chen, Xuefen Fang
Translational Cancer Research  
2026;
15
(4)
:285
.
 (30 April 2026) 
PDF Full Text (27) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Dexamethasone and N-acetylcysteine for the prevention of post-embolization syndrome following transarterial chemoembolization in hepatocellular carcinoma: a systematic review and network meta-analysis
Meihui Cao, Zhiqian Li, Chao Xue
Translational Cancer Research  
2026;
15
(4)
:286
.
 (30 April 2026) 
PDF Full Text (29) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Baseline neutrophil-to-lymphocyte ratio as a prognostic biomarker in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis
Yanli Liu, Chengyan Xu, Shuang Zhao, Yun Chen
Translational Cancer Research  
2026;
15
(4)
:287
.
 (30 April 2026) 
PDF Full Text (35) Reporting Checklist Peer Review File COI Form Open Access Get Permission
DNPEP promotes the growth, metastasis, and cisplatin resistance of tongue squamous cell carcinoma through RACK1/ERK signaling pathway
Jianwei Liu, Zichen Xu, Yuqi Xin, Qingkun Jiang, Zhiliang Nie, Jiaxuan Qiu
Translational Cancer Research  
2026;
15
(4)
:288
.
 (30 April 2026) 
PDF Full Text (29) Reporting Checklist Data Sharing Statement Peer Review File Open Access Get Permission
Identification of immune-related gene signature for predicting prognosis of glioblastoma patients
Lu Ye, Weichao Ma, Jiaoming Li, Yuhan Ming, Fengjuan Zhou, Juan Liu
Translational Cancer Research  
2026;
15
(4)
:289
.
 (30 April 2026) 
PDF Full Text (43) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Construction of a diagnostic model for colorectal cancer based on exosome-related genes: integration of immune cell differentials and molecular docking
Yulai Yin, Li Li, Shuang Liu, Yixuan Xie, Yuwei Li, Yuan Gao, Chen Xu, Yan Wang
Translational Cancer Research  
2026;
15
(4)
:290
.
 (30 April 2026) 
PDF Full Text (35) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Identification of shared diagnostic biomarkers and molecular pathways between chronic kidney disease and renal cell carcinoma using transcriptomics and machine learning
Xiaocheng Peng, Ziyi Wang, Jia Si, Hongsheng Ji, Geyang Xu, Yuanfang Chen, Mulong Du, Ming Xu
Translational Cancer Research  
2026;
15
(4)
:291
.
 (30 April 2026) 
PDF Full Text (62) Reporting Checklist Peer Review File COI Form Open Access Get Permission
An exploratory study on whole-lung radiomics features from computed tomography for prognostic prediction in non-small cell lung cancer with concurrent chemoradiotherapy
Zhongjun Huang, Benlan Li, Yong Hu, Youlong Mo, Tianchu He, Mingdan Zhao, Ya Li, Min Zhang, Ji Xia, Minfang Wang, Xian Liu, Yaping Quan, Hongyan Luo, Lingyun Wang, Weiwei Ouyang, Jie Peng
Translational Cancer Research  
2026;
15
(4)
:292
.
 (30 April 2026) 
PDF Full Text (26) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Digitoxin inhibits the growth of HSC-3 cells by inducing G2/M cell cycle arrest and apoptosis
Ying Rui, Yan Wang, Hongfei Gong, Xuanyu Zhu, Qing Xu, Jing Lin, Jingchen Wei
Translational Cancer Research  
2026;
15
(4)
:293
.
 (30 April 2026) 
PDF Full Text (33) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Mitochondrial gene APOO reprograms lipid metabolism to influence the prognosis of breast cancer
Yupeng Sha, Yi Du, Ming Niu, Quan Yuan, Jiguang Han
Translational Cancer Research  
2026;
15
(4)
:294
.
 (30 April 2026) 
PDF Full Text (38) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Prognostic value and therapeutic implications of HMGA2 in EGFR-mutant non-small cell lung cancer
Yichen Yang, Shixuan Yan, Zitao Liu, Zhibing Luo, Jie Wang, Ganxiu Deng, Jianjun Zhou, Li Xu, Changwen Deng
Translational Cancer Research  
2026;
15
(4)
:295
.
 (30 April 2026) 
PDF Full Text (36) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Lipid metabolism-related molecular typing and prognostic characteristics of cutaneous melanoma
Linxue Li, Lezhen Xu, Wen Shi, Jingyu Zhao, Julin Gu
Translational Cancer Research  
2026;
15
(4)
:296
.
 (30 April 2026) 
PDF Full Text (35) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Diagnostic performances of skin cancers using intensity- and gradient-based features with optical coherence tomography: a pilot study
Wei Gao, Lingyi Lu, Bingjiang Lin, Suling Xu, Alexander A. Moryatov, Sergey V. Kozlov, Valery P. Zakharov, Dmitry V. Kornilin, Ivan A. Bratchenko
Translational Cancer Research  
2026;
15
(4)
:297
.
 (30 April 2026) 
PDF Full Text (27) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Lysosome-dependent cell death reveals a prognostic signature in colorectal cancer via integrated analysis of scRNA-seq and bulk RNA-seq data
Cuihua Li, Dan Cui, Hui Wang, Wentong Yu, Xiaohui Qiu
Translational Cancer Research  
2026;
15
(4)
:298
.
 (30 April 2026) 
PDF Full Text (27) Reporting Checklist Peer Review File COI Form Open Access Get Permission
A prognostic model based on Scissor+ cancer-associated macrophages identified from bulk and single cell RNA sequencing data in ovarian cancer
Yijie Mao, Sulong Xu, Xiaoyan Bao, Biqiong Pan, Hong Chen, Jiefang Lu
Translational Cancer Research  
2026;
15
(4)
:299
.
 (30 April 2026) 
PDF Full Text (30) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Development and internal validation of a multivariable prognostic prediction model in advanced breast cancer patients based on the SEER database
Yuhan Dong, Lizhi Teng, Juntong Du, Shuai Yan, Wenxi Zhao, Hongyue Wang, Weiyang Tao
Translational Cancer Research  
2026;
15
(4)
:300
.
 (30 April 2026) 
PDF Full Text (37) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Prediction of distant metastasis and survival of appendiceal cancer patients: a SEER population-based study
Yanan Guo, Yike Ji, Yuanjia Ren, Linhua Yao, Jing Yu
Translational Cancer Research  
2026;
15
(4)
:301
.
 (30 April 2026) 
PDF Full Text (36) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Preoperative prediction of HER2 expression in gastric cancer based on an enhanced CT radiomics model
Han Feng, Zhi Yang, Mingguo Xie
Translational Cancer Research  
2026;
15
(4)
:302
.
 (30 April 2026) 
PDF Full Text (38) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Metformin suppressed epithelial-mesenchymal transition, cisplatin resistance and metastatic potential of ovarian cancer via inhibiting TGF-β1/Smads
Hualong Tang, Zhengyu Han, Wanglong Zhu, Xinyue Lin, Ji Chen, Jiaofeng Li, Xingqiang He, Mei Chen, Yuhan Yang, Zhiling Yang, Fengtian Li, Jingyi Wang, Xia Meng, Kun Zhang
Translational Cancer Research  
2026;
15
(4)
:303
.
 (30 April 2026) 
PDF Full Text (33) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Tirzepatide attenuates doxorubicin-induced cardiotoxicity via mitochondrial function improvement
Zhong Li, Conghui Li, Han Zhan, Dingqin Cai, Yangyu Ou, Yan Long, Xiaoping Li, Limin Liu
Translational Cancer Research  
2026;
15
(4)
:304
.
 (30 April 2026) 
PDF Full Text (23) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
IGF2BP3 promotes immune evasion and predicts poor prognosis in head and neck squamous cell carcinoma
Wenfu Lu, Guochao Zhang, Yin Ding, Fangyuan Liao, Yaxin Luo, Yan Sui, Xiaowen Zhang, Pingan Wu
Translational Cancer Research  
2026;
15
(4)
:305
.
 (30 April 2026) 
PDF Full Text (29) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Clinical and prognostic implications of KRT19 expression in pancreatic ductal adenocarcinoma
Hyung Jun An, Kwang Bum Cho, Kyung In Shin
Translational Cancer Research  
2026;
15
(4)
:306
.
 (30 April 2026) 
PDF Full Text (36) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Identification and analysis of endoplasmic reticulum stress- related genes in neuroblastoma and construction of a prognostic gene signature
Wenting Lu, Ruixi Zhou, Yan Yue, Junjie Ying, Tao Xiong, Jun Tang, Jing Shi, Hua Wang, Li Zhang, Tiechao Ruan
Translational Cancer Research  
2026;
15
(4)
:307
.
 (30 April 2026) 
PDF Full Text (26) Reporting Checklist Peer Review File COI Form Open Access Get Permission
A distinct form of colorectal cancer: signet ring cell carcinoma
Dong Li, Chuanhua Yang, Feiwu Long, Lili Xiang
Translational Cancer Research  
2026;
15
(4)
:308
.
 (30 April 2026) 
PDF Full Text (21) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Explainable machine-learning prediction of overall and cancer-specific survival in adult triple-negative breast cancer using SEER: a comparative study of nomograms and random survival forests
Yinfang Zhang, Yuanyuan Dou, Chaoxia An, Tongtong Liu, Tingting Shao, Weijie Yang, Wenjing Guo, Peng Song
Translational Cancer Research  
2026;
15
(4)
:309
.
 (30 April 2026) 
PDF Full Text (28) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Machine learning-based early survival prediction in early-onset hepatocellular carcinoma: a SEER-based multi-model comparative study
Huan Ma, Zhenpeng Zeng, Chenjie Xiao, Chunyan Li, Xiaosong Tan, Duanming Du, Ying Wu
Translational Cancer Research  
2026;
15
(4)
:310
.
 (30 April 2026) 
PDF Full Text (34) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Nomogram for predicting cancer-specific mortality risk in endometrial cancer after postoperative radiotherapy
Qingyi Wang, Ailin Tao, Yinfeng Tuo, Jiali Li, Fanglei Liu, Zhihui Deng, Guona Li
Translational Cancer Research  
2026;
15
(4)
:311
.
 (30 April 2026) 
PDF Full Text (30) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Identification and validation of ZAP70 as a potential biomarker associated with T cell infiltration in lung adenocarcinoma
Lunqiang Zhang, Xiuying Li, Fang Jin
Translational Cancer Research  
2026;
15
(4)
:312
.
 (30 April 2026) 
PDF Full Text (28) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Clinical features, central nervous system risk, and therapeutic outcomes in primary sinonasal diffuse large B-cell lymphoma: a retrospective cohort study of 94 patients
Na Yao, Chengji Wang, Monan Niu, Lei Yang, Jia Cong, Jin Ye, Xin Li, Jing Yang, Liqiang Wei, Liang Wang
Translational Cancer Research  
2026;
15
(4)
:313
.
 (30 April 2026) 
PDF Full Text (27) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Integrated single-cell and bulk RNA sequencing reveals novel biomarkers of invasive adenocarcinoma subtypes in lung adenocarcinoma
Xiaoming Wu, Xuxia Ye, Bo Wang, Zhoule Li, Chengnan Fang, Jian Xu, Mengli Wu
Translational Cancer Research  
2026;
15
(4)
:314
.
 (30 April 2026) 
PDF Full Text (30) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Clinical outcomes and prognostic factors of systemic therapy combined with interventional treatment in hepatocellular carcinoma: a multicenter retrospective case series
Shilong Yu, Tongguo Si, Chu Wang, Donghui Liu, Gang Jin, Xudong Zhang, Huikai Li, Mao Yang, Weihao Zhang, Yongfei Guo, Rentao Li, Huiwen Wang, Shijie Li, Miao Xu, Dongfeng He, Haifeng Liu
Translational Cancer Research  
2026;
15
(4)
:315
.
 (30 April 2026) 
PDF Full Text (42) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
The effects of adjuvant radiotherapy on survival outcomes in polymorphous adenocarcinoma: a retrospective cohort study
Makayla R. Matthews, Victoria I. Fonseca, Samuel Auger, Christopher A. Pede, Ramez Phillips, Jason Tasoulas, Christopher Blake Sullivan
Translational Cancer Research  
2026;
15
(4)
:316
.
 (30 April 2026) 
PDF Full Text (30) Reporting Checklist Peer Review File COI Form Open Access Get Permission
RNF112 mediates immunosuppression to inhibit the proliferation of cervical cancer by Foxm1
Huiying Pan, Lei Bao, Wei Shi, Jing Wan
Translational Cancer Research  
2026;
15
(4)
:317
.
 (30 April 2026) 
PDF Full Text (42) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
MTFR2 regulated the proliferation, apoptosis, migration, and invasion of endometrial cancer cells through the Drp1/MFN1 signaling pathway mediated mitochondrial fission
Xuefei Bai, Min Wei, Qi Wang, Yongxiu Yang
Translational Cancer Research  
2026;
15
(4)
:318
.
 (30 April 2026) 
PDF Full Text (48) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Survival benefit of adjuvant radiotherapy for gallbladder cancer patients with stage IIIA: a population based, propensity score-matched study
Xin Zhao, Yunfeng Qiao, Long He, Congdun Ran
Translational Cancer Research  
2026;
15
(4)
:319
.
 (30 April 2026) 
PDF Full Text (54) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Exosomal P4HA3: a promising biomarker for diagnosis and prognosis in gastric cancer
Jinquan Lin, Chunyu Wang, Qingli Fang, Zhi Zhao
Translational Cancer Research  
2026;
15
(4)
:320
.
 (30 April 2026) 
PDF Full Text (42) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
The effect of astragaloside IV on doxorubicin-induced cardiotoxicity in young mice: exploring its cardioprotective effect during childhood tumor chemotherapy
Huai-Yang Liu, Jing-Jing Yang, Jin-Sheng Gao, Dan Tang, Ya-Jing Tian, Jia-Cheng Wang, Jin-Hu Yang, Shao-Fang Gao
Translational Cancer Research  
2026;
15
(4)
:321
.
 (30 April 2026) 
PDF Full Text (47) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Loss of GGT6 promotes colorectal cancer progression and correlates with poor prognosis: a study based on multi-database mining and functional validation
Yu Yang, Jiamin Li, Shangzhiyu Gong, Chenyi Zhao, Lulu He, Feng Guo
Translational Cancer Research  
2026;
15
(4)
:322
.
 (30 April 2026) 
PDF Full Text (37) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Comprehensive analysis and validation of the prognostic value of glycosylation- and mitophagy-related genes for head and neck squamous cell carcinoma
Qiaoling Lu, Li Ying, Lang Ling, Wu Hui, Xinbin Wang
Translational Cancer Research  
2026;
15
(4)
:323
.
 (30 April 2026) 
PDF Full Text (29) Reporting Checklist Peer Review File COI Form Open Access Get Permission
LncRNA ELFN1-AS1 promotes colon cancer occurrence and progression by regulating the miR-191-5p/ZBTB34 axis
Yue Jiang, Yanmei Hou, Yongjun Du, Xiangdong Yang
Translational Cancer Research  
2026;
15
(4)
:324
.
 (30 April 2026) 
PDF Full Text (32) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Clinical value and cost-effectiveness analysis of conditionally approved anticancer drugs in China from 2015 to 2023
Zhiming Huang, Xuanzhuang Lu, Haoyang Wang, Jinlian Li, Rong Shao, Jinping Xie
Translational Cancer Research  
2026;
15
(4)
:325
.
 (30 April 2026) 
PDF Full Text (37) Reporting Checklist Peer Review File COI Form Open Access Get Permission
The potential of ATF5 as a prognostic marker and therapeutic target in cancer: insights from bioinformatics analysis and experimental validation
Yanrong Zhao, Hongyu Yang, Tingting Cai, Zhizhong Hao, Qingju Sun, Dongmeng Qian, Ming Hu
Translational Cancer Research  
2026;
15
(4)
:326
.
 (30 April 2026) 
PDF Full Text (57) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Clinical significance of circulating tumor DNA monitoring based on TP53 mutation in high-grade serous ovarian cancer patients
Heejung Jung, Ok-Ju Kang, Young-Jae Lee, Sung Wan Kang, Min-Seo Lee, Shin-Wha Lee, Yong Man Kim
Translational Cancer Research  
2026;
15
(4)
:327
.
 (30 April 2026) 
PDF Full Text (40) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Tree-based model for diffuse-type gastric cancer prognostication: a population study based on the Surveillance, Epidemiology, and End Results database
Lei Cai, Yeqi Sun, Beibei Lv, Wenjing Su, Jia Li
Translational Cancer Research  
2026;
15
(4)
:328
.
 (30 April 2026) 
PDF Full Text (46) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Network pharmacology approach and experimental verification of Danzhi Xiaoyao Powder for breast cancer treatment based on UHPLC-Q-Orbitrap HRMS
Kan Ni, Nan Xu, Xun Lu, Changjiang Gu, Cheng Lu
Translational Cancer Research  
2026;
15
(4)
:329
.
 (30 April 2026) 
PDF Full Text (59) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Development and validation of a macrophage-related prognostic model for overall survival in ovarian cancer via integrated RNA sequencing analysis
Tao Yu, Guangji Yang, Dongyan Ren, Yantao Li, Chong Yue, Qin Yang, Jie Zhang
Translational Cancer Research  
2026;
15
(4)
:330
.
 (30 April 2026) 
PDF Full Text (41) Reporting Checklist Peer Review File COI Form Open Access Get Permission
A machine learning-based basement membrane gene signature model for predicting ovarian cancer survival
Qian Hu, Yuan-Yue Li, Jing Ge
Translational Cancer Research  
2026;
15
(4)
:331
.
 (30 April 2026) 
PDF Full Text (56) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Adaptive radiotherapy based on nodal response to induction chemotherapy in nasopharyngeal carcinoma: a retrospective dose de-escalation analysis
Wenxuan Huang, Weisi Wang, Yizhi Ge, Dan Zong, Lanfang Zhang, Lijun Wang, Shengfu Huang, Xia He
Translational Cancer Research  
2026;
15
(4)
:332
.
 (30 April 2026) 
PDF Full Text (41) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Physical activity and cancer survival: the role of peripheral blood immune and inflammatory markers in reducing mortality—a retrospective cohort study based on NHANES 1999–2018
Xin Liu, Xuefei Fan, Chenggong Li, Xinquan Liang, Pingping Hu, Jiandong Zhang
Translational Cancer Research  
2026;
15
(4)
:333
.
 (30 April 2026) 
PDF Full Text (44) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Characterizing immune heterogeneity in gastric cancer by high-throughput T-cell receptor sequencing: predictive clonotypes and functional signatures
Tianhua Liu, Zhengrong Chen, Guilian Cheng, Liming Xu, Lei Gan, Zhenyu Ye, Xudong Shen
Translational Cancer Research  
2026;
15
(4)
:334
.
 (30 April 2026) 
PDF Full Text (49) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Fibulin-5 (FBLN5) as a context-dependent pan-cancer regulator: integrated multi-omics analysis reveals dual roles in tumor progression and therapeutic resistance
Jingtao Tong, Kaitai Liu, Yajie Shi, Yanggang Dan, Bingchuan Hu, Hui Zhang
Translational Cancer Research  
2026;
15
(4)
:335
.
 (30 April 2026) 
PDF Full Text (38) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission

Review Article

Targeting “undruggable” cancer proteins: pharmacological challenges and emerging strategies
Juan Luiz Coelho-Silva, Natália Sudan Parducci, Maria Fernanda Lopes Carvalho, Vahid Vahedian, Keli Lima, Bruna Oliveira de Almeida, João Agostinho Machado-Neto
Translational Cancer Research  
2026;
15
(4)
:336
.
 (30 April 2026) 
PDF Full Text (78) Peer Review File COI Form Open Access Get Permission
A narrative review of cinobufacini for endometrial cancer: mechanisms and therapeutic implications
Liying Xu
Translational Cancer Research  
2026;
15
(4)
:337
.
 (30 April 2026) 
PDF Full Text (44) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Tumor cell plasticity in non-small cell lung cancer: the role of microRNA and implications for diagnosis, prognosis and treatment
Iyare Izevbaye
Translational Cancer Research  
2026;
15
(4)
:338
.
 (30 April 2026) 
PDF Full Text (36) Peer Review File COI Form Open Access Get Permission
The double-edged sword of tumor-targeted treatment: the influence of targeted therapy on the heart
Yexuan Huang, Liwen Chen, Cheng Ding, Cheng Zou, Zhaoliang Su, Xiaozheng Shu, Yan Wu
Translational Cancer Research  
2026;
15
(4)
:339
.
 (30 April 2026) 
PDF Full Text (43) Peer Review File COI Form Open Access Get Permission
CRISPR technology in ovarian cancer research: advances from gene editing to precision diagnosis and therapy
Yuanling Zhang, Yinhua Tan, Yuanyuan Du, Rui Xiang, Yi Liu
Translational Cancer Research  
2026;
15
(4)
:340
.
 (30 April 2026) 
PDF Full Text (30) Peer Review File COI Form Open Access Get Permission
Metronomic chemotherapy combined with immunotherapy in solid tumor: a systematic review
Shaoxing Li, Zongxi Li, Xiangjie Liu, Hua Yu
Translational Cancer Research  
2026;
15
(4)
:341
.
 (30 April 2026) 
PDF Full Text (43) Reporting Checklist Open Access Get Permission
Targeting the MICA/B-NKG2D axis in cancer: from molecular structure to immunotherapeutic strategies—a narrative review
Yuwei Zheng, Wanyi Ding, Bingbing Chen, Caizheng Geng, Xiaowei Li
Translational Cancer Research  
2026;
15
(4)
:342
.
 (30 April 2026) 
PDF Full Text (42) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Precision, prevention and progress: charting two decades of change in gynaecological oncology—a narrative review
Sabina Ioana Nistor, Ruyu Shao, Jacopo Conforti, Francis Gardner, Federico Ferrari, Lamiese Ismail, Xiaoyu Niu, Desheng Yao, Hooman Soleymani majd
Translational Cancer Research  
2026;
15
(4)
:343
.
 (30 April 2026) 
PDF Full Text (141) Reporting Checklist Peer Review File COI Form Open Access Get Permission
PARP inhibitors in the treatment of ovarian cancer: a narrative review
Yan Wang, Xiaoli Li, Yudan Yang, Xiufang Lv, Kang Wang, Haochen Li, Xiaohao Liu, Ke Jin, Ming Gao
Translational Cancer Research  
2026;
15
(4)
:344
.
 (30 April 2026) 
PDF Full Text (47) Reporting Checklist Peer Review File COI Form Open Access Get Permission

Editorial Commentary

Starving leukemia: nicotinamide phosphoribosyltransferase-dependent nicotinamide adenine dinucleotide salvage links metabolic vulnerability to therapeutic sensitivity in acute myeloid leukemia
Juan Luiz Coelho-Silva, Diego Antonio Pereira-Martins, João Agostinho Machado-Neto
Translational Cancer Research  
2026;
15
(4)
:345
.
 (30 April 2026) 
PDF Full Text (36) Peer Review File COI Form Open Access Get Permission
Postoperative proton therapy in uterine and cervical cancer: promising evidence but remaining questions
Lars Wessel, Nathalie Arians
Translational Cancer Research  
2026;
15
(4)
:346
.
 (30 April 2026) 
PDF Full Text (47) Peer Review File COI Form Open Access Get Permission
From prognosis to precision: interpreting HER2DX assay in early HER2-positive breast cancer
Yuhei Yamaguchi, Yuki Kojima, Kan Yonemori
Translational Cancer Research  
2026;
15
(4)
:347
.
 (30 April 2026) 
PDF Full Text (70) Peer Review File COI Form Open Access Get Permission
Can whole genome data analysis be used to personalize breast cancer care?
Wanping Xu, Edward R. Sauter
Translational Cancer Research  
2026;
15
(4)
:348
.
 (30 April 2026) 
PDF Full Text (29) COI Form Open Access Get Permission
Post-transplant oral decitabine and cedazuridine maintenance in high-risk acute myeloid leukemia or myelodysplastic syndrome
Thura Win Htut, Farhad Ravandi
Translational Cancer Research  
2026;
15
(4)
:349
.
 (30 April 2026) 
PDF Full Text (77) Peer Review File COI Form Open Access Get Permission
Do ethnic differences influence the response to immunotherapy in advanced cervical cancer?
Giovanna Vieira Giannecchini, Ana Beatriz Tavares Filgueiras, Diocésio Alves Pinto de Andrade, Andreia Cristina de Melo
Translational Cancer Research  
2026;
15
(4)
:350
.
 (30 April 2026) 
PDF Full Text (31) Peer Review File COI Form Open Access Get Permission
Anti-HCV treatment and risk for extrahepatic cancers: evidence of benefits with questions remaining
Hanyang Liu, Frank Tacke
Translational Cancer Research  
2026;
15
(4)
:351
.
 (30 April 2026) 
PDF Full Text (42) Peer Review File COI Form Open Access Get Permission
Risk-reducing surgery, risk-reducing medication, and surveillance in young BRCA carriers with breast cancer: considering all the options
Nicola Flaum, Ashu Gandhi, Sacha J. Howell, D. Gareth Evans
Translational Cancer Research  
2026;
15
(4)
:352
.
 (30 April 2026) 
PDF Full Text (36) Peer Review File COI Form Open Access Get Permission
Iodine seed-marking protocol for response-guided axillary de-escalation after neoadjuvant therapy in node-positive breast cancer
Sergi Vidal-Sicart, Renato A. Valdés Olmos
Translational Cancer Research  
2026;
15
(4)
:353
.
 (30 April 2026) 
PDF Full Text (31) Peer Review File COI Form Open Access Get Permission
Too much, too soon?—trastuzumab deruxtecan in the first line metastatic setting
Ashley P. Davenport, Margaret E. Gatti-Mays
Translational Cancer Research  
2026;
15
(4)
:354
.
 (30 April 2026) 
PDF Full Text (55) Peer Review File COI Form Open Access Get Permission
Residual disease after neoadjuvant therapy in HER2-positive breast cancer: biology, burden, or both?
Élise Di Lena, Kazuaki Takabe
Translational Cancer Research  
2026;
15
(4)
:355
.
 (30 April 2026) 
PDF Full Text (44) Peer Review File COI Form Open Access Get Permission
Refining breast cancer risk estimation in carriers of pathogenic BRCA2 variants
Délio Marques Conde, Renata Lazari Sandoval
Translational Cancer Research  
2026;
15
(4)
:356
.
 (30 April 2026) 
PDF Full Text (51) Peer Review File COI Form Open Access Get Permission
Sentinel lymph node biopsy in early-stage oral squamous cell carcinoma: reassessing its role in contemporary practice
Chin Shien Lin, Leandro Luongo Matos
Translational Cancer Research  
2026;
15
(4)
:357
.
 (30 April 2026) 
PDF Full Text (33) Peer Review File COI Form Open Access Get Permission
Moderately hypofractionated IMPT with pelvic nodal irradiation for high-risk prostate cancer: an emerging standard or an incremental step?
Elías Gomis Sellés, Antonio J. Conde, Fernando López Campos, Felipe Couñago
Translational Cancer Research  
2026;
15
(4)
:358
.
 (30 April 2026) 
PDF Full Text (51) COI Form Open Access Get Permission
Small device, big impact: how a simple chairside 3D-printed retractor reshapes dose and patient experience in head and neck radiotherapy
Paulo Sérgio da Silva Santos, Vinícius Rizzo-Marques
Translational Cancer Research  
2026;
15
(4)
:359
.
 (30 April 2026) 
PDF Full Text (50) Peer Review File COI Form Open Access Get Permission
Review Article 
The management of brain necrosis as a result of SRS treatment for intra-cranial tumors
Uresh Patel, Ankush Patel, Charles Cobb, Tara Benkers, Sandra Vermeulen
Published online: 28 August 2014
PDF Full Text (131371) COI Form Open Access Get Permission
Meta-Analysis 
Prognostic value of TTF-1 expression in patients with non-small cell lung cancer: a meta-analysis
Ping Zhan, Qian Qian, Benjamin Wan, Tristan D. Yan, Li-Ke Yu
Published online: 05 March 2013
PDF Full Text (78120) COI Form Open Access Get Permission
Review Article 
Common applications of next-generation sequencing technologies in genomic research
Chien-Yueh Lee, Yu-Chiao Chiu, Liang-Bo Wang, Yu-Lun Kuo, Eric Y. Chuang, Liang-Chuan Lai, Mong-Hsun Tsai
Published online: 05 March 2013
PDF Full Text (69169) COI Form Open Access Get Permission
Original Article 
Effect of fasting therapy in chemotherapy-protection and tumorsuppression: a systematic review
Lei Sun, Yong-Jiang Li, Xi Yang, Ling Gao, Cheng Yi
Published online: 28 April 2017
PDF Full Text (49931) COI Form Open Access Get Permission
Biological basis of IORT 
Immune effects of high dose radiation treatment: implications of ionizing radiation on the development of bystander and abscopal effects
Ithaisa Sologuren, Carlos Rodríguez-Gallego, Pedro Carlos Lara
Published online: 25 February 2014
PDF Full Text (49230) COI Form Open Access Get Permission
Review Articles 
Nanoparticles in radiation therapy: a summary of various approaches to enhance radiosensitization in cancer
Deep Kwatra, Anand Venugopal, Shrikant Anant
Published online: 26 September 2013
PDF Full Text (48773) COI Form Open Access Get Permission
Review Articles 
Alternative pathways of non-homologous end joining (NHEJ) in genomic instability and cancer
Rositsa Dueva, George Iliakis
Published online: 19 June 2013
PDF Full Text (48538) COI Form Open Access Get Permission
Editorial 
Morphine, when used for treating patients with acute pancreatitis, could be more risky than previously suspected
Juan Iovanna, Maria Cecilia Mallmann
Published online: 24 October 2017
PDF Full Text (47835) COI Form Open Access Get Permission
Review Article 
Do alkaline phosphatases have great potential in the diagnosis, prognosis, and treatment of tumors?
Tingting Jiang, Qun Zeng, Jun He
Published online: 20 October 2023
PDF Full Text (45734) Peer Review File COI Form Open Access Get Permission
Review Article 
EGFR first- and second-generation TKIs—there is still place for them in EGFR-mutant NSCLC patients
Niki Karachaliou, Manuel Fernandez-Bruno, Jillian Wilhelmina Paulina Bracht, Rafael Rosell
Published online: 19 January 2019
PDF Full Text (42040) COI Form Open Access Get Permission
Review Article 
Cancer biomarker discovery and validation
Nicolas Goossens, Shigeki Nakagawa, Xiaochen Sun, Yujin Hoshida
Published online: 18 June 2015
PDF Full Text (38947) COI Form Open Access Get Permission
Review Articles 
Tumor microenvironment and nanotherapeutics
Meenakshi Upreti, Amar Jyoti, Pallavi Sethi
Published online: 26 September 2013
PDF Full Text (37817) COI Form Open Access Get Permission
Biological basis of IORT 
Cell and molecular response to IORT treatment
Luigi Minafra, Valentina Bravatà
Published online: 25 February 2014
PDF Full Text (36141) COI Form Open Access Get Permission
Editorial 
The CROSS road in neoadjuvant therapy for esophageal cancer: long-term results of CROSS trial
Ian Wong, Simon Law
Published online: 29 September 2016
PDF Full Text (33405) COI Form Open Access Get Permission
Review Articles 
DNA damage tolerance: a double-edged sword guarding the genome
Gargi Ghosal, Junjie Chen
Published online: 19 June 2013
PDF Full Text (30254) COI Form Open Access Get Permission
Review Articles 
DNA crosslinking damage and cancer - a tale of friend and foe
Yaling Huang, Lei Li
Published online: 19 June 2013
PDF Full Text (30098) COI Form Open Access Get Permission
Review Article 
Renal cell carcinoma: the search for a reliable biomarker
Nicholas J. Farber, Christopher J. Kim, Parth K. Modi, Jane D. Hon, Evita T. Sadimin, Eric A. Singer
Published online: 30 June 2017
PDF Full Text (29333) COI Form Open Access Get Permission
Review Article 
EGFR and HER2: is there a role in ovarian cancer?
Eleonora Teplinsky, Franco Muggia
Published online: 13 February 2015
PDF Full Text (29221) COI Form Open Access Get Permission
Review Article 
Multiple keratoacanthoma centrifugum marginatum—a case report and systematic review
Yiman Wang, Wenling Zhao, Yueping Zeng, Li Li, Hongzhong Jin
Published online: 30 December 2018
PDF Full Text (29118) COI Form Open Access Get Permission
Review Articles 
MDM2 and MDMX: alone and together in regulation of p53
Miriam Shadfan, Vanessa Lopez-Pajares, Zhi-Min Yuan
Published online: 01 August 2012
PDF Full Text (28930) COI Form Open Access Get Permission

Original Article

A recursively partitioned mixture model for clustering time-course gene expression data
Devin C. Koestler, Carmen J. Marsit, Brock C. Christensen, Karl T. Kelsey, E. Andres Houseman
Statistical strategies for microRNAseq batch effect reduction
Yan Guo, Shilin Zhao, Pei-Fang Su, Chung-I Li, Fei Ye, Charles R. Flynn, Yu Shyr
Defining functional changes in the brain caused by targeted stereotaxic radiosurgery
Vipan K. Parihar, Munjal M. Acharya, Dante E. Roa, Omar Bosch, Lori-Ann Christie, Charles L. Limoli
A chain reaction approach to modelling gene pathways
Gary C. Cheng, Dung-Tsa Chen, James J. Chen, Seng-jaw Soong, Coral Lamartiniere, Stephen Barnes
Oncolytic virus-mediated tumor radiosensitization in mice through DNA-PKcs-specific shRNA
Takashi Kon, Xiuwu Zhang, Qian Huang, Zhonghui Yang, Shanling Liu, Bin Yan, Fang Li, He Wang, Chuan-Yuan Li
Identification of cancer mechanisms through computational systems modeling
Zhen Qi, Eberhard O. Voit
Frameless single-isocenter intensity modulated stereotactic radiosurgery for simultaneous treatment of multiple intracranial metastases
Steven K. M. Lau, Xiao Zhao, Ruben Carmona, Erik Knipprath, Daniel R. Simpson, Sameer K. Nath, Gwe-Ya Kim, Jona A. Hattangadi, Clark C. Chen, Kevin T. Murphy
Matrix metalloproteinase (MMP) and immunosuppressive biomarker profiles of seven head and neck squamous cell carcinoma (HNSCC) cell lines
Amber M. Bates, Maria Paula Gomez Hernandez, Emily A. Lanzel, Fang Qian, Kim A. Brogden
Coexpression and expression quantitative trait loci analyses of the angiogenesis gene-gene interaction network in prostate cancer
Hui-Yi Lin, Chia-Ho Cheng, Dung-Tsa Chen, Y. Ann Chen, Jong Y. Park
How are lung cancer risk perceptions and cigarette smoking related?—testing an accuracy hypothesis
Lei-Shih Chen, Kimberly A. Kaphingst, Tung-Sung Tseng, Shixi Zhao
Alcohol intake patterns for cancer and non-cancer individuals: a population study
Hui-Yi Lin, Paige Fisher, Darian Harris, Tung-Sung Tseng
Application of Bayesian predictive probability for interim futility analysis in single-arm phase II trial
Dung-Tsa Chen, Michael J. Schell, William J. Fulp, Fredrik Pettersson, Sungjune Kim, Jhanelle E. Gray, Eric B. Haura

Review Article

Integrative clustering methods for high-dimensional molecular data
Prabhakar Chalise, Devin C. Koestler, Milan Bimali, Qing Yu, Brooke L. Fridley
Sparse principal component analysis in cancer research
Ying-Lin Hsu, Po-Yu Huang, Dung-Tsa Chen
An improved understanding of cancer genomics through massively parallel sequencing
Jamie K. Teer
Pathogenesis of serous, extra-uterine Müllerian epithelial cancer and therapeutic implications
Louis Dubeau
Cancer biomarker discovery and validation
Nicolas Goossens, Shigeki Nakagawa, Xiaochen Sun, Yujin Hoshida
The promise and challenge of ovarian cancer models
Noor Hasan, Anders W. Ohman, Daniela M. Dinulescu
Prostate cancer: unmet clinical needs and RAD9 as a candidate biomarker for patient management
Howard B. Lieberman, Alex J. Rai, Richard A. Friedman, Kevin M. Hopkins, Constantinos G. Broustas
Exosomal lncRNAs as new players in cell-to-cell communication
Mihnea Dragomir, Baoqing Chen, George A. Calin
Repurposing DNA repair factors to eradicate tumor cells upon radiotherapy
Souparno Bhattacharya, Aroumougame Asaithamby
Translational research in radiation-induced DNA damage signaling and repair
Jac A. Nickoloff, Mary-Keara Boss, Christopher P. Allen, Susan M. LaRue
Genetically engineered mouse models for studying radiation biology
Katherine D. Castle, Mark Chen, Amy J. Wisdom, David G. Kirsch
Renal cell carcinoma: the search for a reliable biomarker
Nicholas J. Farber, Christopher J. Kim, Parth K. Modi, Jane D. Hon, Evita T. Sadimin, Eric A. Singer
Advances on immunotherapy in genitourinary and renal cell carcinoma
Gregory P. Botta, Eric Granowicz, Carrie Costantini
The role of novel immunotherapies in non-Hodgkin lymphoma
Allyson Pishko, Sunita D. Nasta
MDMX under stress: the MDMX-MDM2 complex as stress signals hub
Anna de Polo, Varunika Vivekanandan, John B. Little, Zhi-Min Yuan
Do p53 stress responses impact organismal aging?
Paul Hasty, Judith Campisi, Z. Dave Sharp
Pharmacological targeting of mutant p53
Samuel Kogan, Darren Carpizo
Regulation of the Mdm2-p53 signaling axis in the DNA damage response and tumorigenesis
Michael I. Carr, Stephen N. Jones
Regulation of cytotoxic T-cell responses by p53 in cancer
Mitchell W. Braun, Tomoo Iwakuma
The IGF-1R/AKT pathway determines cell fate in response to p53
Lei Duan, Carl G. Maki
Intra molecular interactions in the regulation of p53 pathway
Jiandong Chen
TP53 mutations in epithelial ovarian cancer
Yu Zhang, Lan Cao, Daniel Nguyen, Hua Lu
Modulation of the p53 family network by RNA-binding proteins
Chris Lucchesi, Jin Zhang, Xinbin Chen
Radiomics in head and neck cancer: from exploration to application
Andrew J. Wong, Aasheesh Kanwar, Abdallah S. Mohamed, Clifton D. Fuller
Prostate cancer radiomics and the promise of radiogenomics
Radka Stoyanova, Mandeep Takhar, Yohann Tschudi, John C. Ford, Gabriel Solórzano, Nicholas Erho, Yoganand Balagurunathan, Sanoj Punnen, Elai Davicioni, Robert J. Gillies, Alan Pollack
Positron emission tomography/computerized tomography for tumor response assessment—a review of clinical practices and radiomics studies
Wei Lu, Wengen Chen
The emerging field of radiomics in esophageal cancer: current evidence and future potential
Peter SN. van Rossum, Cai Xu, David V. Fried, Lucas Goense, Laurence E. Court, Steven H. Lin
Sphingosine-1-phosphate in inflammatory bowel disease and colitis-associated colon cancer: the fat’s in the fire
Jung H. Suh, Julie D. Saba
Computational methods and opportunities for phosphorylation network medicine
Yian Ann Chen, Steven A. Eschrich

Editorial

Focusing in on radiation induced brain injury
M. Kerry O’Banion
Targeting HSP90 in malignant gliomas: onalespib as a potential therapeutic
Naomi Lomeli, Daniela A. Bota
Lessons learned from rindopepimut treatment in patients with EGFRvIII-expressing glioblastoma
David C. Binder, Erik Ladomersky, Alicia Lenzen, Lijie Zhai, Kristen L. Lauing, Sebastian D. Otto-Meyer, Rimas V. Lukas, Derek A. Wainwright
New light on the pancreatic cyst conundrum
Nathan A. Berger
HNF1A, KRT81, and CYP3A5: three more straws on the back of pancreatic cancer?
Andrew J. Scott, John C. Wilkinson
Bevacizumab as an adjuvant therapy for glioblastoma in elderly patients: the facts
Kristopher A. Lyon, Jason H. Huang
Disulfiram combats cancer via crippling valosin-containing protein/p97 segregase adaptor NPL4
Nan Ding, Qianzheng Zhu
Hypofractionated whole breast irradiation is cost-effective—but is that enough to change practice?
Apar Gupta, Nisha Ohri, Bruce G. Haffty
Cost-effectiveness in managing skeletal related events in breast cancer: a strategy of less-intense dosing schedule of bone modifying agents
Sri Harsha Tella, Anuhya Kommalapati, Ryan K. Singhi
CRISPR-based genetic interaction maps inform therapeutic strategies in cancer
Poornima Ramkumar, Martin Kampmann
Smooth sailing for immunotherapy for unresectable stage III nonsmall cell lung cancer: the PACIFIC study
Melin J. Khandekar, Rakesh Jain
The evolving role of molecular profiling in prostate cancer: basal and luminal subtyping transcends tissue of origin
Omar Y. Mian, Rahul D. Tendulkar, Mohamed E. Abazeed
Serrated polyposis: the problem of definition and its relationship to the population at risk for syndrome-related colorectal cancer
Joanne P. Young, Timothy J. Price, Susan Parry
Multifactorial regulators of tumor programmed death-ligand 1 (PD-L1) response
R. Dixon Dorand, Agne Petrosiute, Alex Y. Huang
Therapeutic targeting of oncogenic KRAS in pancreatic cancer by engineered exosomes
Theresa L. Whiteside
TIC10/ONC201—a potential therapeutic in glioblastoma
Georg Karpel-Massler, Markus D. Siegelin
IDH mutational status and the immune system in gliomas: a tale of two tumors?
Bryan D. Choi, William T. Curry
ONC201: a new treatment option being tested clinically for recurrent glioblastoma
Marie D. Ralff, Amriti R. Lulla, Jessica Wagner, Wafik S. El-Deiry
When better still might not be good enough
Waldemar Debinski
Androgen receptor antagonism and impact on inhibitors of androgen synthesis in prostate cancer therapy
Vincent C. O. Njar
Co-inhibitory receptor programmed cell death protein 1 targets co-stimulatory CD28
Leonardo Chicaybam, Prasad S. Adusumilli
Exosome mediated phenotypic changes in lung cancer pathophysiology
Yoshihisa Shimada, John D. Minna
Signatures of field cancerization: a step towards earlier detection of esophageal adenocarcinoma
Aaron D. DeWard, Rebecca J. Critchley-Thorne
From tumorigenesis to microenvironment and immunoregulation: the many faces of focal adhesion kinase and challenges associated with targeting this elusive protein
Felicia L. Lenzo, William G. Cance
New incriminating evidence against IGF2
Wen Ding, Lina A. Shehadeh
Targeting cancer with tumor-specific therapeutic strategies—metabolic reprogramming beyond the Warburg effect
Paul Grippo, Ajay V. Maker
Branched chain amino acid metabolism and cancer: the importance of keeping things in context
Elizabeth M. Selwan, Aimee L. Edinger
RIPK1-TRAF2 interplay on the TNF/NF-κB signaling, cell death, and cancer development in the liver
Satomi Yamamoto, Tomoo Iwakuma
Genome-based modeling for adjusting radiotherapy dose (GARD)-a significant step toward the future of personalized radiation therapy
Michael J. Baine, Chi Lin
Rogue one: another faction of the Wnt empire implicated in assisting GBM progression
Riasat Ahsan, Shivani Baisiwala, Atique U. Ahmed
Normalizing tumoral vessels to treat cancer: an out-of-the-box strategy involving TIE2 pathway
Juan Fueyo, Mohammad B. Hossain, Teresa Nguyen, Candelaria Gomez-Manzano
Exploring gold nanoparticle interactions with proteins and the tumor microenvironment in biological systems
Li Tian, Ashley Chang, Marites P. Melancon
IL-6, cancer and cachexia: metabolic dysfunction creates the perfect storm
James P. White
Low-frequency ultrasound may improve drug penetration in colonic mucosa
Qiubing Chen, Bo Xiao, Didier Merlin
Dividing and conquering the variation among variants in EML4-ALK lung cancer
Trever G. Bivona
Unlocking the epigenetic code of T cell exhaustion
Jiazhu Wu, Huidong Shi
KDM1 links nuclear GSK3β to epigenetic alterations
Weijie Guo, Binhua P. Zhou
Moving the mountain in advanced non-small-cell lung cancer: evolving immunotherapies for a dire disease
Deepa Rangachari, Daniel B. Costa
Taming immune suppressor: application of myeloid-derived suppressor cells in anti-cancer gene therapy
Bhagelu R. Achyut, Ali S. Arbab
Neuroendocrine differentiation in prostate cancer: key epigenetic players
Karishma Gupta, Sanjay Gupta
PD-L1 is a diverse molecule regulating both tumor-intrinsic signaling and adaptive immunosuppression
Kim A. Brogden, Shireen Vali, Taher Abbasi
Mesenchymal stromal cells and interferon α (IFNα) in cancer immunotherapy
Diana Saleiro, Sara G. Radecki, Leonidas C. Platanias
The potential role of curcumin in prostate cancer: the importance of optimizing pharmacokinetics in clinical studies
Keith T. Schmidt, William D. Figg
Information-dense analysis for information-dense understanding
Nikola A. Ivica, Mandeep Kaur, Guangan Hu, Jianzhu Chen
The “liquid biopsy” in non-small cell lung cancer—not quite ready for prime time use
Angel Qin, Nithya Ramnath
Immune infiltration, glioma stratification, and therapeutic implications
Manny D. Bacolod, Sarmistha Talukdar, Luni Emdad, Swadesh K. Das, Devanand Sarkar, Xiang-Yang Wang, Francis Barany, Paul B. Fisher
Balancing redox stress: anchorage-independent growth requires reductive carboxylation
Clint.A Stalnecker, Ahmad.A Cluntun, Richard.A Cerione
Myeloid leukemia switch as immune escape from CD19 chimeric antigen receptor (CAR) therapy
Fabiana Perna, Michel Sadelain
Harnessing protein kinase A activation to induce mesenchymal-epithelial programs to eliminate chemoresistant, tumor-initiating breast cancer cells
Alex J. Gooding, William P. Schiemann
Actionable intelligence provided by pancreatic cancer genomic landscape: are targets for curative therapy on the map?
Nathan A. Berger
Microtubule targeting agents in glioma
Anda-Alexandra Calinescu, Maria G. Castro
Moving molecular subtypes to the clinic in gastric cancer
Joseph Chao, Jeeyun Lee, Samuel J. Klempner
Intraoperative subtyping of lung adenocarcinoma: an unmet need
Nurlan Aliyev, Yusuke Takahashi, Shaohua Lu, Marissa Mayor, Prasad S. Adusumilli
Emerging roles of FGF signaling in hepatocellular carcinoma
Nana Zheng, Wenyi Wei, Zhiwei Wang
Tregs, Helios and tumor immunity: the sun has not yet risen
Angela M. Thornton, Ethan M. Shevach
Immune checkpoint regulator: a new assignment proposed for the classic adhesion molecule P-selectin glycoprotein ligand-1
Jiaxuan Chen, Carolyn A. Haller, Elliot L. Chaikof
Sarcomatoid renal cell carcinoma: genomic insights from sequencing of matched sarcomatous and carcinomatous components
Brandon J. Manley, James J. Hsieh
Multimodal action of ONECUT2 in driving neuroendocrine prostate cancer
Salma Kaochar, Nicholas Mitsiades

Letter to the Editor

Epigenetic regulation of PD-L1 expression and pancreatic cancer response to checkpoint immunotherapy
Chunwan Lu, Kebin Liu
Synthetic lethality vs. synthetic viability due to PARP1 and BRCA2 loss
Xia Ding, Shyam K. Sharan

Correspondence

Targeted attack: mechanisms by which ovarian cancers suppress the immune system
Irina V. Tiper, Tonya J. Webb

Brief Report

The impact of neighborhood disadvantage on health-related quality of life among African American and white cancer survivors
Chien-Ching Li, Alicia K. Matthews, Anjali Asthana, Raj C. Shah

Research Highlight

Butyrate consumption of differentiated colonocytes in the upper crypt promotes homeostatic proliferation of stem and progenitor cells near the crypt base
Scott J. Bultman

Commentary

Molecular heterogeneity of localized prostate cancer: more different than alike
Jeffrey J. Tosoian, Emmanuel S. Antonarakis
A crowded, but still varied, space: brigatinib in anaplastic lymphoma kinase-rearranged non-small cell lung cancer
Sawsan Rashdan, David E. Gerber
MOAP-1, UBR5 and cisplatin resistance in ovarian cancer
Scott T. Eblen, Amber Bradley
Exportin 1/chromosome region maintenance 1 as a therapeutic target for lung cancer
Weimin Gao
The role of tumor-derived exosomes in epithelial mesenchymal transition (EMT)
Theresa L. Whiteside
[18F]-choline PET/CT as an imaging biomarker for primary liver cancers
Zhenghong Lee
Empiric H. pylori therapy—10-day concomitant, bismuth quadruple or 14-day triple therapy: none is best
Yoshio Yamaoka, David Y. Graham
JAK3-mediated phosphorylation of EZH2: a novel mechanism of non-canonical EZH2 activation and oncogenic function
Theodoros Karantanos, Vassiliki A. Boussiotis
Cisplatin, etoposide, and irinotecan for relapsed small-cell lung cancer
Angel Qin, Gregory P. Kalemkerian
Helicobacter pylori vacuolating cytotoxin and gastric cancer risk: reconsidered
Muhammad Miftahussurur, Yoshio Yamaoka, David Y. Graham
Colonic crypts are natural gatekeepers of microbial metabolites to protect stem cells
Praveen Kumar Vemula, Venkatakrishna Rao Jala
Helios—controller of Treg stability and function
Claire Chougnet, David Hildeman
Directing abiraterone metabolism: balancing the scales between clinical relevance and experimental observation
Jon K. Obst, Marianne D. Sadar
Novel insights into the oncogenic function of the SMYD3 lysine methyltransferase
Pawel K. Mazur, Or Gozani, Julien Sage, Nicolas Reynoird
Fat lure: adipocytes attract cancer cells out of the prostate
Alexandra M. Blee, Haojie Huang
Impact of genomic heterogeneity associated with acquired anti-EGFR resistance in colorectal cancers
Guoli Chen, Ming-Tseh Lin

Editorials

Into the eye of the storm: breast cancer’s somatic mutation landscape points to DNA damage and repair
Joanne Ngeow, Emily Nizialek, Charis Eng

Perspective

Circular RNAs and competing endogenous RNA (ceRNA) networks
Apratim Mitra, Karl Pfeifer, Ki-Sun Park
The STAMPEDE trial: paradigm-changing data through innovative trial design
Bradley C. Carthon, Emmanuel S. Antonarakis
Regulation of chemo-sensitivity in ovarian cancer via a stroma dependent glutathione pathway
Derek B. Oien, Jeremy Chien, Nikki Cheng
Feed your gut with caution!
Vishal Singh, Beng San Yeoh, Matam Vijay-Kumar
Precision oncology: identifying predictive biomarkers for the treatment of metastatic renal cell carcinoma
Parth K. Modi, Nicholas J. Farber, Eric A. Singer

Letter to the Editors

Multiscale modeling of glioblastoma
Huaming Yan, Mónica Romero-López, Lesly I. Benitez, Kaijun Di, Hermann B. Frieboes, Christopher C. W. Hughes, Daniela A. Bota, John S. Lowengrub

Research Highlights

A balancing act for breast cancer? Everolimus for hormone receptor positive patients
Stephanie B Wheeler, Katherine Reeder-Hayes, Anne-Marie Meyer

Review Articles

New developments in treatment planning and verification of particle beam therapy
Reinhard W. Schulte, Andrew J. Wroe
Externally modulated theranostic nanoparticles
Cordula Urban, Alexander S. Urban, Heather Charron, Amit Joshi
Intestinal stem cell injury and protection during cancer therapy
Jian Yu
Cancer stem cells in glioma: challenges and opportunities
Jialiang Wang, Yufang Ma, Michael K. Cooper
Tumor microenvironment and nanotherapeutics
Meenakshi Upreti, Amar Jyoti, Pallavi Sethi
Hematopoietic stem cell senescence and cancer therapy-induced long-term bone marrow injury
Lijian Shao, Yingying Wang, Jianhui Chang, Yi Luo, Aimin Meng, Daohong Zhou
Role of p53 in regulating tissue response to radiation by mechanisms independent of apoptosis
Chang-Lung Lee, Jordan M. Blum, David G. Kirsch
DNA ligases as therapeutic targets
Alan E. Tomkinson, Timothy R.L. Howes, Nathaniel E. Wiest
DNA damage tolerance: a double-edged sword guarding the genome
Gargi Ghosal, Junjie Chen
DNA double strand break repair via non-homologous end-joining
Anthony J. Davis, David J. Chen
DNA crosslinking damage and cancer - a tale of friend and foe
Yaling Huang, Lei Li
Convergence of nanotechnology with radiation therapy—insights and implications for clinical translation
Dev Kumar Chatterjee, Tatiana Wolfe, Jihyoun Lee, Aaron P Brown, Pankaj Kumar Singh, Shanta Raj Bhattarai, Parmeswaran Diagaradjane, Sunil Krishnan
MDM2 and MDMX: alone and together in regulation of p53
Miriam Shadfan, Vanessa Lopez-Pajares, Zhi-Min Yuan
Sensitization of tumor cells to cancer therapy by molecularly targeted inhibition of the inhibitor of nuclear factor κB kinase
Lijian Shao, Lixian Wu, Daohong Zhou
Role of DNA-dependent protein kinase catalytic subunit in cancer development and treatment
Feng-Ming Hsu, Shichuan Zhang, Benjamin P.C. Chen
SIRT2 is a tumor suppressor that connects aging, acetylome, cell cycle signaling, and carcinogenesis
Seong-Hoon Park, Yuming Zhu, Ozkan Ozden, Hyun-Seok Kim, Haiyan Jiang, Chu-Xia Deng, David Gius, Athanassios Vassilopoulos
Normal tissue protection for improving radiotherapy: where are the Gaps?
Pataje G.S. Prasanna, Helen B. Stone, Rosemary S. Wong, Jacek Capala, Eric J. Bernhard, Bhadrasain Vikram, C. N. Coleman
Improving chemoradiotherapy with nanoparticle therapeutics
Michael Joseph Eblan, Andrew Zhuang Wang
Gold nanoparticles in radiation research: potential applications for imaging and radiosensitization
Jay F. Dorsey, Lova Sun, Daniel Y. Joh, Alon Witztum, Ajlan Al Zaki, Gary D. Kao, Michelle Alonso-Basanta, Stephen Avery, Andrew Tsourkas, Stephen M. Hahn
Molecular mechanisms involved in tumor repopulation after radiotherapy
Wooi-Loon Ng, Qian Huang, Xinjian Liu, Mary Zimmerman, Fang Li, Chuan-Yuan Li
Efficacy of combination treatment modalities for intermediate and advanced hepatocellular carcinoma: intra-arterial therapies, sorafenib and novel small molecules
Julio A. Gutierrez, Robert G. Gish

Original Articles

Third generation gold nanoplatform optimized for radiation therapy
Rajiv Kumar, Houari Korideck, Wilfred Ngwa, Ross I. Berbeco, G. Mike Makrigiorgos, Srinivas Sridhar
Utilizing signature-score to identify oncogenic pathways of cholangiocarcinoma
Tzu-Hung Hsiao, Hung-I Harry Chen, Jo-Yang Lu, Pei-Ying Lin, Charles Keller, Sarah Comerford, Gail E. Tomlinson, Yidong Chen

Below are the latest Translational Cancer Research articles published online ahead of print publication.

Journal highlight more

Translational Cancer Research is an international, open access, peer-reviewed journal indexed in Scopus and Science Citation Index Expanded (SCIE), focusing on original, science-based researches on clinical, basic and translational aspects. It publishes laboratory studies of novel therapeutic interventions, clinical trials which evaluate new treatment paradigms for cancer, results of novel research investigations which bridge the laboratory and clinical settings including risk assessment, cellular and molecular characterization, prevention, detection, diagnosis and treatment of human cancers with the overall goal of improving the clinical care of cancer patients and etc.

Indexing

Translational Cancer Research is indexed and covered by

Message from the Editor-in-Chief

Visual Abstract

Visual Absract
Visual abstracts, also called 'graphical abstracts' or 'infographics,' are images that summarize the essential information of manuscripts, providing an easily and expediently understood overview of study findings at a glance. More >>

Reviewers more

In 2026, TCR reviewers continue to make outstanding contributions to the peer review process. More >>
In 2025, TCR reviewers continue to make outstanding contributions to the peer review process. More >>
In 2024, TCR reviewers continue to make outstanding contributions to the peer review process. More >>

Membership

Member since 2021

Publishing Information

Translational Cancer Research is published by AME Publishing Company

AME Publishing Company

Translational Cancer Research is published with support from Wolters Kluwer

Wolters Kluwer

The official journal of Society for Translational Medicine (STM), Hong Kong

Society for Translational Medicine (STM), Hong Kong

Social Media